The present study was designed to demonstrate the potential of an optimized histology directed protein identification combined with imaging mass spectrometry technology to reveal and identify molecules associated to ectopic calcification in human tissue. As a proof of concept, mineralized and non-mineralized areas were compared within the same dermal tissue obtained from a patient affected by Pseudoxanthoma elasticum, a genetic disorder characterized by calcification only at specific sites of soft connective tissues. Data have been technically validated on a contralateral dermal tissue from the same subject and compared with those from control healthy skin. Results demonstrate that this approach 1) significantly reduces the effects generated by techniques that, disrupting tissue organization, blend data from affected and unaffected areas; 2) demonstrates that, abolishing differences due to inter-individual variability, mineralized and non-mineralized areas within the same sample have a specific protein profile and have a different distribution of molecules; 3) avoiding the bias of focusing on already known molecules, reveals a number of proteins that have been never related to the disease nor to the calcification process, thus paving the way for the selection of new molecules to be validated as pathogenic or as potential pharmacological targets.
Introduction
Calcium and phosphate deposition in soft connective tissues occurs in a number of genetic diseases, in metabolic disorders, such as uremia, hyperparathyroidism and diabetes, or secondary to inflammation or atherosclerosis. Numerous proteins have been identified to be involved in bone calcification as well as in ectopic mineralization, suggesting that an active and dynamic balance of pro-calcifying and anti-calcifying mechanisms take place in both physiological and pathological calcification [1] . Nevertheless it is still unclear whether calcification affects particular matrix components in specific organs/tissues, whereas other areas remain unaffected and which molecules/pathways could be targeted for pharmacological approaches. To address these questions, investigations performed so far have looked at the specific expression/localization of already known proteins [2] or have used cell lines and tissue extracts to pick up unknown gene/proteins by means of "omic" techniques [3] [4] [5] . However, the major difficulty of these techniques is the ability to analyse a large number of proteins without losing the morphology and the tissue architecture and, even more importantly, to discriminate which proteins belong to normal or to pathologic areas. Therefore, in this study, on-tissue analyses were carried out by Matrix-assisted laser desorption/ionization mass spectrometry (MALDI MS) (profiling and imaging) [6] [7] as a consolidated tool for the analysis of biological and clinical tissue samples [8] [9] [10] [11] [12] . This approach has several advantages: i) endogenous (locally synthesised by cells) as well as exogenous (derived from the blood stream) molecules can be analysed directly from the tissue in their native environment, without homogenization, thus preserving spatial relationship of molecules within a specimen; ii) it does not require the use of antibodies; iii) it can map the expression of hundreds of proteins from a single (8 μm thick) tissue section.
However, MALDI MS, although leading to the detection of a large number of peptides and small proteins (up to 25 kDa), cannot be currently utilized for larger proteins (exceeding 25 kDa). In order to detect also proteins larger than 25 kDa, we have applied a histologydirected mass spectrometry protein identification [13] using hydrogel discs as carriers for the enzyme, thus allowing the digestion to take place directly on discrete tissue areas preserving the relationship between molecular information and tissue architecture.
As the technology advances, the application of MALDI MS as well as of miniaturized hydrogel devices for histology directed on-tissue protein digestion in the clinic will continue to expand, enabling to play a central role in the diagnosis and prognosis of diseases and in the evaluation of patient's therapy. Therefore, we have combined this MS-based technology in order to investigate skin biopsies from a patient affected by Pseudoxanthoma elasticum, a rare genetic disorder characterized by a progressive calcification occurring in specific areas of soft connective tissues, whereas other regions remain unaffected [14] . Proteomic analyses were performed on mineralized and non-mineralized areas of the same biopsy, and data compared with those from a control healthy tissue.
Material and Methods

Tissue specimen collection
Patient was a woman 46 years old affected by Pseudoxanthoma elasticum (PXE). The disease was clinically diagnosed at the age of 15 years by the presence of typical dermal alterations (Fig. 1a) and by ocular angioid streaks. Biomolecular analyses confirmed the clinical diagnosis of PXE revealing two causative missense mutations in the ABCC6 gene: one on exon 12 (c.1553G>A, p.Arg518Gln) and the other on exon 24 (c.3389C>T, p.Thr1130Met).
Control tissue was obtained from a woman 47 years old undergoing elective cosmetic surgical procedures. No connective tissue alterations were present, nor any clinically relevant condition.
Consent was obtained to use these specimens for research purposes in accordance with the Declaration of Helsinki protocol.
After surgery, skin samples were immediately placed in fixatives for morphological analyses or frozen in liquid nitrogen and stored at -80°C until ready for processing and preparation for mass spectrometry analysis.
Light and electron microscopy
For the demonstration of calcified elastic fibres, skin specimens (approximately 1cm 3 ) were routinely fixed in 10% (v/v) formalin in water, dehydrated and embedded in paraffin. Five to seven micron thick sections were collected on glass slides and processed for the von Kossa stain. Briefly, sections were deparaffinized and hydrated, stained for approximately hour with 5% (w/v) silver nitrate in water under a UV-lamp, rinsed with water, immersed for 5 minutes in 5% (w/v) thiosulfate in water and finally observed with a Zeiss Axiophot light Microscope (Jena, Germany).
For ultrastructural observations, specimens were cut in 1mm 3 fragments and routinely fixed in 2.5% (v/v) glutaraldehyde (Agar Scientific, Stansted, UK) in Tyrode's buffer pH 7.2 (135 mM NaCl, 2.8 mM KCl, 1 mM MgCl 2 , 2 mM CaCl 2 , 12 mM NaHCO 3 , 0.4 mM NaH 2 PO 4 , 5.5 mM Glucose), postfixed in 1% (v/v) osmium tetroxide (Agar Scientific) in Tyrode's buffer, dehydrated and embedded in Spurr resin (Agar Scientific). Ultrathin sections (approximately 70-80nm) were stained with uranyl acetate and lead citrate and observed with a TEM Jeol 2010 (Jeol, Tokyo, Japan)
MS-based techniques: the strategy
A workflow of the analytical approach and technologies we have combined in this study is presented in Fig. 2 .
A typical experimental design for MALDI MS protein analysis is made of 3 steps: sample preparation, data acquisition (profiling and imaging) and data processing.
In the profiling experiment, the laser beam irradiates each sample spot and ion signals from hundreds of consecutive shots are averaged across the droplet surface generating a mass spectrum. Protein patterns from a discrete number of spots or areas can be compared allowing the analysis of molecules within their native environment.
For imaging analyses (MALDI IMS), spectra are recorded for each x,y coordinate into the mass range 2.5-30 kDa and finally plotted in 2-dimensions for ion density map construction (for each m/z value). Hundreds of protein-specific ion density maps correlated with tissue architecture can be generated. Each pixel (spectrum) contains many proteins and endogenous peptides that are individually displayed as a function of their position and relative intensity within the tissue. Spectra from different regions of interest (i.e papillary, reticular and mineralized dermis) can be used for statistical analysis.
In a parallel experiment a histology-directed on-tissue protein digestion approach has been applied. Briefly, on-tissue protein digestion was performed using hydrogel discs (1 mm in diameter embedded with trypsin solution) placed on the regions of interest of cryosectioned samples. After digestion, discs were first manually removed from the tissue surface, then properly treated (solvent extracted) and used for LC-MS/MS analysis followed by database search for protein identification.
Tissue preparation, fixation and contaminant removal
We have recently optimized techniques for IMS analysis of human skin and have used only minor modifications of our published procedures [15, 16] . Fresh frozen human skin blocks (approximately 1cm 3 ) were sectioned at 8 μm using a cryostat (CM 3050 S, Leica Microsystems GmbH, Wetzlar, Germany) set at -22 °C.
For MS analysis, serial cryosections were collected, mounted on ITO conductive glass slides (Delta Technologies, Stillwater, MN) and allowed to dry at room temperature for 3 min prior to matrix deposition. Each conductive slide was rinsed with a Carnoy's (60 mL of ethanol, 30 mL of chloroform, and 10 mL of acetic acid) washing protocol [17] in order to remove interfering species such as salts and lipids [18, 19] .
For histological orientation, serial cryosections were mounted on glass microscope slides (Fisher Scientific, Pittsburgh, PA) and stained with haematoxylin-eosin and alizarin red, respectively. Briefly, for haematoxylin-eosin staining slides were placed in 95% ethanol 
MALDI-MS
A crucial step in MALDI MS analyses is represented by the choice of matrix type and of matrix deposition mode (e.g., droplet for profiling by MALDI MS and thin homogenous matrix layer for imaging MALDI MS). Most of matrices are specific to a mass range or family of compounds, moreover, each matrix type has specific ionization property and this determines differences in the MS spectrum.
Sinapinic acid, for instance, is the matrix of choice for large proteins, whereas α-cyano-4-hydroxy-cinnamic acid (CHCA) is the preferred matrix for peptide mapping.
All MS analyses were performed by an AutoflexSpeed MALDI TOF spectrometer (Bruker Daltonics, Billerica, MA, USA), equipped with a linear TOF (time-of-flight) analyser, operating in positive polarity, accumulating 500 laser shots per position in the case of the IMS experiment, and 1000 shots per matrix spot in the case of the profiling experiment, at 1000 Hz laser frequency over the m/z range of 2,500-30,000 Da. The laser intensity was adjusted before each experiment to yield optimal results. Images were acquired at 50 μm rastering (spatial resolution). Data acquisition, pre-processing (baseline subtraction of each mass spectrum) and data visualization/process verification were performed using the Flex software suite (FlexControl 3.0, FlexAnalysis 3.0, FlexImaging 3.0) from Bruker Daltonics. Prior to generation of ion density maps, spectra were normalized to the total ion current (TIC) in order to minimize spectrum-to-spectrum differences in peak intensity.
Tissue profiling by MALDI MS-
A robotic acoustic droplet ejection system was used for matrix deposition (Portrait 630 reagent multi-spotter, Labcyte, Sunnyvale, CA) [20] . On a 8 μm-cryosection mounted on ITO conductive glass slide, 2 different areas of interest, papillary and reticular dermis (calcified and non calcified), were targeted for repeated deposition of matrix made of Sinapinic acid (20 mg/mL) in 1:1 acetonitrile/ trifluoroacetic-acid (Sigma Aldrich, St. Louis, MO, USA) at 0.1% (v/v) aq.) that was deposited over a series of 6 iterations at 10 droplets (120nL) per iteration. After completion of matrix deposition, slides were immediately returned to vacuum desiccation at room temperature until MS analysis the same day (figure 2).
Tissue imaging by MALDI IMS-For imaging mass spectrometry, 8 μm-
cryosections mounted on ITO conductive glass slide were coated of a homogenous thin layer of matrix using a sublimation device (Chemglass Life Science, Vineland, NJ, USA). Sublimation of sinapinic acid (300 mg) was carried out at 145° C, at a pressure of 45 mTorr and, after 15 minutes, coating became uniform. The aim of this procedure was to allow the mass spectrometer to acquire spectra with a spatial resolution higher than that is possible by an array of evenly spaced spots. Finally, tissue sections were quickly rehydrated at 85° C for 3 min to allow matrix recrystallization.
Protein identification by LC-MS/MS
Tissue proteins were first digested following an histology-directed in situ digestion method using hydrogel discs for trypsin deposition onto the specific tissue regions of interest (e.g.: dermis, mineralized dermis) [21] . Digestion was performed at 50°C for 4 hours. Hydrogels (1 mm diameter) were re-hydrated for 15 mins using 20 μL of 1 μg/mL trypsin (in 100 mM ammonium bicarbonate) and then placed over the tissue region of interest (skin mineralized dermis, adjacent dermis) onto the whole tissue surface guided by the histological features on corresponding serial H&E stained tissue section. The tissue sections were incubated in a oven at 50 °C for 4 hours to allow protein digestion. Each hydrogel disc was removed from the tissue section and placed in separate eppendorf tubes. Peptides imbibed into the microwell hydrogels were extracted by organic (50% acetonitrile/5% formic acid) and aqueous (100 mM ammonium bicarbonate) solvents, a process that was repeated three times. The supernatant collected from each extraction were combined and dried in a centrifugal vacuum concentrator (SPD Speedvac, Thermo Scientific, Waltham, MA, USA). The reconstituted extracts (20 μL, 0.1% (v/v) formic acid) were stored at -20°C until LC-MS/MS analysis was performed.
The reconstituted extracts were analysed by a 70 minutes data dependent LC-MS/MS analysis as already described [13] . Thus, MS/MS spectra were searched via SEQUEST against a human database (UniprotKB -reference proteome set) that also contained a reversed version for each of the entries [22] (figure 2). The criteria used to accept protein identification included the extent of sequence coverage, the number of matched peptides (almost 3 peptides/protein) and a probabilistic score at p < 0.05 equivalent to 95% confidence. All protein identifications underwent false discovery rate (FDR) that measures the expected proportion of false positives among the statistically significant findings. The FDR cutoff was set at 0% for all proteins in Scaffold (Proteome Software).
Statistical analysis
Multiple spectra (N=400) per region of interest (papillary dermis, mineralized dermis, reticula dermis) were selected from the IMS data. Comparisons of different cutaneous regions of interest were conducted using principal component analysis (PCA) to generate classification models based on protein profiles patterns. In order to understand how the molecular microenvironment within the mineralized dermis itself can influence adjacent areas, PCA was performed comparing the mineralized dermis with the adjacent dermis and also with the normal dermis from healthy subject. Protein spectra from the MALDI IMS sequences were compared. PCA were performed because this is a statistical method commonly used to reduce the dimensionality of a multivariate data set to lower dimensions while retaining most of the information by displaying and ranking its variance within a data set. The PCA transforms the original coordinate system (peaks) into the new coordinate system (PC). The new coordinates are called principal components or PCs; so, the first PC (PC1) points in the direction of the highest variance, while the second PC (PC2) points in the direction of the second highest variance. This statistical tool was used to generate classification models based on protein profile patterns. These data were used to confirm the existence of two disparate sub-regions within the dermis in pseudoxanthoma elasticum disorder affected subjects. The same statistical analysis was carried out for the papillary and reticular dermis from a healthy subject. Statistical analyses were carried out using ClinProTools software from Bruker (Bruker Daltonics, Billerica, MA, USA).
Functional analysis
To discover the Gene Ontology (GO) categories with significantly enriched protein numbers, the MS identified proteins were processed by the DAVID (Database for Annotation, Visualization and Integrated Discovery) bioinformatics resource v. 6.7, freely available at http://david.abcc.ncifcrf.gov. The significance of "protein"-term enrichment was assured by a modified Fisher's exact test with a p value <0.01. The protein list was also functionally evaluated applying the UniProtKB/Gene Ontology/Biological Process data processing (http://www.uniprot.org/).
The list of gene IDs of the differentially expressed spots identified were used to perform functional analysis with DAVID 6.7. The list of gene IDs was loaded into the online tool (http://david.abcc.ncifcrf.gov/) clicking on Functional annotation clustering and selecting gene ID as identifier and gene list as list type. After submission of the list, functional classification was performed on the basis of Gene Ontology.
STRING 9.1 Network Analysis
Possible connections among identified proteins were analyzed by a protein and gene network software. For each protein, UniProtKB entry numbers and related gene names were acquired in UniProtKB and used for network generation by the use of STRING 9.1 (http:// www.string-db.org/) [23, 24] . The UniProtKB entry numbers were inserted into the input form as "multiple proteins" and "Homo sapiens" was selected as the reference organism.
Results
Assessment of calcified areas
Morphological analyses of PXE skin confirm the typical accumulation of deformed calcified elastic fibres in the middle reticular dermis, as assessed by von Kossa staining on paraffin embedded tissue (Fig. 1B) and by ultrastructural observations (Fig. 1C) . As clearly shown in figure 1C calcified elastic fibres are characterized by enlarged and tortuous shape with irregular contour due to the progressive deposition of mineral precipitates starting from the elastin core. Only few small normal areas of amorphous elastin are visible at the periphery of the fibres.
MALDI Mass Spectrometry and Imaging Mass Spectrometry
MALDI MS protein profiling shows, within the same PXE specimen, a number of m/z ions with differences in peak's relative intensity and distribution depending on the areas considered (Fig. 3A) .
To further implement these data, IMS analyses (Fig. 3C) , integrated with histological observations (Fig. 3B) , were carried out on control and PXE cryosectioned samples at the spatial resolution of 50 μm. Haematoxylin-eosin and alizarin red staining were used to visualize tissue morphology and calcified areas, respectively (Fig. 3B) . PXE data have been technically validated on sections from the contralateral axilla of the same patient (Figs. 3B,  C) . MS and histology data must be combined in order to produce structural and molecular information and to create molecular 2D maps. The distribution and the relative expression of hundreds of m/z ions, within morphologically different tissue regions, were displayed. For example, calgizzarin (ion at m/z 11651) is mainly distributed close to the epidermis without differences between control and PXE specimens. In the case of thymosin beta-4 (TYB-4) (m/z 4965), this protein is density mapped in the papillary dermis adjacent to the mineralized region in both PXE samples, whereas it is localized within the whole dermis in controls, as previously described in normal healthy skin [15] . By contrast, the cleaved form of TYB-4 (m/z 4748) is always present in the papillary dermis, whereas it is absent in the control reticular dermis and in the mineralized regions. Other ions, as m/z 3183 and 3406, appear primarily localized within the mineralized reticular dermis compared to control skin, whereas others, as m/z 3429, are similarly distributed in the superficial layer of control and PXE skin, or are barely expressed as in the case of m/z 15874 (Fig. 3C) . These data indicate that a differential protein mapping may characterize PXE samples compared to healthy skin.
In order to highlight similarities and differences among ion patterns, MALDI mass spectra recorded from different control and PXE dermal regions were compared by principal component statistical analysis (PCA). When the resulting plot is coloured based on the tissue region, it appears that control skin molecules from the papillary and the reticular dermis are largely intermingled and no sample grouping is clearly evident (Fig. 4A ).
By contrast, PCA plots show that, in PXE, proteins from the mineralized skin can be grouped in a region clearly separated from those derived either from the papillary (Fig. 4B) or the reticular non-mineralized dermis (Fig. 4C) . Only a few proteins were clearly identified, most being characterized on the basis of their presence within a mass range of 3-25 kDa.
Histology-directed identification of proteins from mineralized and non-mineralized tissue regions
The term "histology-directed" describes the use of histology combined with MS techniques, conducted directly on serial and consecutive tissue sections, for the evaluation of proteome changes affecting a specific tissue region. By histology it is possible to investigate the morphology of the tissue and to distinguish pathologic from adjacent, presumably healthy, areas. For protein identification we have selected tissue regions according to the histology and then we have placed hydrogel discs (microwell reactors containing trypsin) within nonmineralized and mineralized areas of the same PXE specimen.
All identified proteins (acronym, full name and SwissProt accession number) are listed in Table 1 and divided according to their presence in mineralized or in non-mineralized regions or in both areas. Additional details on mass spectrometry data are provided in Supplementary Table S1 . Fig. 5A shows that out of 242 proteins, 78 (32%) have been identified in the nonmineralized tissue, 147 (61%) in both mineralized and non-mineralized dermis and 17 (7%) in the calcified area. Moreover, considering the nonexclusive localization criteria used in GO, proteins can appear in several annotation terms within the GO categories (i.e. biological process, molecular function and cellular component).
Gene ontology (GO) classification of identified proteins
According to their contribution to one or to more biological processes, identified proteins appear mainly involved in cellular processes, cellular component organization and biogenesis, multicellular organismal processes and in the response to stimulus (Fig. 5B and Supplemental Table S2 ). As far as their molecular functions, most of the identified proteins exhibit binding and structural molecular activity (Fig. 5C and Supplementary Table S3) .
Finally, on the basis of their localization, 78 proteins were in the extracellular region and 166 in organelle structures (Fig. 5D and Supplementary Table S4 ).
Despite their different distribution and functional properties, the great majority of the identified proteins are actually related one to the other, as clearly highlighted by the results of the analysis performed using the STRING software. In Fig. 6 the predicted proteinprotein interaction (PPI) networks are shown based on evidence (Fig. 6A) and actions (Fig.  6B) , respectively. In the evidence and in the action PPI, the type of evidence characterizing the protein-protein association and the mode of action of proteins are described by lines of different colour.
Discussion
Ectopic calcification is a pathologic mineralization process of soft connective tissues associated to a number of genetic as well as acquired disorders frequently responsible for age-related clinical complications [25] .
Within this context, Pseudoxanthoma elasticum, due to ABCC6 gene mutations, is characterized by progressive calcification affecting, through only partially known mechanisms, specific areas of soft connective tissues, as skin, blood vessels and the Bruch's membrane in the eye [14] . Abnormal expression of inhibitors of calcification as matrix-Glaprotein, pyrophosphate, fetuin-A [3, [26] [27] [28] have been related to the disease, however it is still unclear why, within each tissue, there are areas of mineralization together with uncalcified regions. It has been suggested that unknown factors within soft connective tissues may allow or counteract the deposition of mineral hydroxyapatite crystals at specific sites [29] .
PXE represents the perfect model to test the relevance of the combined approach of MALDI MS (profiling and imaging) together with histology-driven MS protein identification to improve the characterization of the diseased tissue and to investigate a large number of proteins on a single tissue section. This aspect is crucial in the case of reduced sample availability and represents a significant improvement compared to other techniques requiring to separately analyse larger amount of tissue by histology, immunohistochemistry and/or proteomics. Moreover, this approach avoids the bias of focusing on already known molecules or to evaluate proteins without a precise separation between affected (mineralized) and unaffected (non-mineralized) areas within the same tissue specimen.
In particular, with respect to tissue architecture and morphology, IMS can produce spatially resolved mass spectrometric data that can be combined with histological observations. In addition, with a single measurement, IMS allows the direct analysis of molecules/peptides' localisation and of their relative intensity within the tissue. A different protein distribution between PXE and control skin, as well as between different regions within the same specimen has been demonstrated, avoiding differences due to individual variability. One of the most striking variation between PXE skin samples and control specimens is the peculiar localization of TYB-4 in the PXE papillary dermis, whereas protein expression is barely detectable in the mineralized reticular dermis. TYB-4 exerts a protective role on ROSmediated damages in many cell types, including fibroblasts [30] . The observation that its expression is negligible in the calcified dermis may indicate that the mineralized tissue is more susceptible to oxidative stress. Consistently, chronic perturbances of redox balance have been demonstrated in vivo and in vitro in PXE [31, 32] , as well as in other conditions related to ectopic calcification [33, 34] . Moreover, PCA plots clearly show that the mineralized dermis is characterized by a peculiar proteomic profile. IMS measures molecules by their mass. Although this is sufficient for smaller analytes, such as lipids or peptides that can be directly identified on the tissue itself, molecules with molecular weights larger then 25 kDa cannot be identified as easily [35] .
To tackle this problem, we have therefore enzymatically treated the tissue in order to cleave proteins into peptides that can be readily ionized, detected and subsequently identified. In particular, we have used a histology directed in situ digestion method using hydrogel discs for the enzyme deposition onto the specific tissue region of interest (Fig. 2) [21] . The presence/absence of proteins from the analysed samples depends on the enzyme used for the digestion and on the technique applied for the extraction. In our work we have used only trypsin, without adding any reduction and alkylation agent. Therefore, the number of proteins cleaved, as well as the type of proteins identified, is a consequence of this choice. Moreover, we have applied very stringent parameters during the process of protein identification. This approach may limit the number of listed proteins, although increasing the reliability of the identification of detected proteins and therefore a comparative analysis was done in the same experimental conditions on different areas of the same sample. Trypsin digestion allowed to reveal hundreds of proteins involved in many biological processes or belonging to cellular and extracellular components, however, we have preferred to list only 242 proteins resulting from the high stringent conditions used in the identification process (confidence for analyte identification >95% and FDR set at 0%).
The presence of cellular and metabolic proteins common to all tissue regions indicate that cells are spread within the tissue, independently from the presence of calcification, as previously demonstrated by morphological observations showing numerous fibroblasts closed to mineralized elastic fibres [36] . Interestingly, it has to be underlined that 78 and 17 proteins appear characteristic of the non-calcified and of the mineralized dermis, respectively. Since the enzyme used for digestion and the stringency of the parameters applied for databases searching, affect the number of identified proteins, possibly because of the experimental conditions used, some proteins already known to be involved in the calcification process (i.e. alkaline phosphatase, ectonucleotide pyrophosphatase/ phosphodiesterase 1) were not detected, whereas others were clearly identified.
For instance, carbonic anhydrase (CA2) is specifically associated to the non-mineralized region, whereas it is absent from areas of ectopic calcification. Interestingly, CA2 loss of function has been actually related to osteopetrosis and to arterial and cerebral calcification [37] . Although the clinical phenotype in PXE is not so severe as that described in patients affected by osteopetrosis, never the less it could be suggested that CA2 may be involved in a complex network of factors promoting or inhibiting mineral precipitates through changes in the local environment [38] .
In the calcified dermis we have demonstrated the presence of molecules as ApoE, an apolipoprotein that, besides its role in lipid metabolism, is considered a "pathologic chaperone" [39] promoting the accumulation of insoluble proteins within the extracellular compartment. In agreement with this finding, insoluble aggregates of fibrillar and amorphous proteins have been described in association to calcified elastic fibres within the PXE dermis [29] . Elastic structures interact with several matrix components, including minor collagens [40] . To be noted that in the present study, alpha 1, 2 and 3 chains of collagen type VI have been identified in both mineralized and non-mineralized regions, whereas a newly discovered alpha 6 chain of collagen type VI, whose biological role is still under investigation, appears unexpectedly associated to the calcified dermis. It has been proposed that the alpha 6 chain could represent alternatively spliced variants leading to abnormal collagen microfibrillar structures possibly related to elastin-associated components [41, 42] . If these changes represent markers of extracellular matrix alterations, thus favouring mineral deposition, it has been never explored and may be worth of additional investigation on a larger number of specimens/subjects.
All data are technically reproducible since the same results were obtained from the contralateral skin sample and therefore support the rationale to further look at specific molecules/pathways. Moreover, as the technology advances, the analysis of fresh frozen tissue at higher spatial resolution provides new possibilities to investigate tissue morphology at a molecular level using small amount of tissue, a requirement extremely important in the case of reduced sample availability.
Finally, the application of MALDI MS (profiling and imaging) as well as of the miniaturized hydrogel devices for histology directed on-tissue protein digestion allow us to expand the use of these approaches to the clinic, paving the way for the selection of new molecules to be validated as pathogenic or as potential pharmacological target.
In conclusion, although validating the pathogenic role of specific molecules was not purpose of the present study, these data, for the first time, demonstrate the significance of these technical approaches for studying ectopic calcification.
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